Tag Archives: Food and Drug Administration

Google Unveils New Pharma Ads

Image via CrunchBase Google just showed off mockups of its fancy new pharma ads at FDA’s social media hearing, on November 12. A few months back, the big G mentioned that it was working on ads to appease both pharmaceutical marketers and FDA, but this is the first time most people got to lay eyes […]
Posted in Strategy | Also tagged , , , , , , | 2 Comments

AZ’s First Corporate Blog Falls Flat

Currently, if patients or doctors look for specific drug information on AZ Health Connections, AstraZeneca’s new corporate communications blog, they won’t find any. And that’s exactly how AZ—along with pretty much every other pharma company engaged in the social media sphere—wants it. “The one area we’re trying not to engage is specific questions about disease […]
Posted in E-Media | Also tagged , , , , , , | 3 Comments

FDA Readies More Warning Letters, Fast Enforcement Action

Image by Getty Images via Daylife FDA officials have been promising stiffer enforcement of manufacturing and marketing requirements for several months, and commissioner Margaret Hamburg is moving full-speed ahead to fulfill those predictions. Last month, FDA announced it will issue warning letters quickly when it finds violations and will require manufacturers to respond promptly. Too […]
Posted in FDA | Also tagged , , , , , , | Leave a comment

Woodcock Under Investigation

Image by Getty Images via Daylife An FDA director has come under fire by a generics firm claiming that the director of the Center for Drug Evaluation and Research favored a competitor in a wanton act of conflict of interest. The Wall Street Journal this morning broke the story that Janet Woodcock is under investigation […]
Posted in Strategy | Also tagged , , , , , | Leave a comment

Feds Publically Spank Bad Investigators

Image via Wikipedia FDA, late on Friday, announced that it would ramp up efforts to keep naughty investigators from working for companies with approved or pending drug applications. “The FDA views any deviation from its high standards for developing or marketing drugs and devices as a potential threat to patient safety and public health,” stated […]
Posted in Regulatory | Also tagged , , , | Leave a comment
  • Categories

  • Meta